CordenPharma Caponago


Managing Director:

Angelo Colombo

 

Corden Pharma Caponago S.p.A.

Viale dell’Industria, 3
20867 Caponago
Monza Brianza
Italy
Phone:+39 02 95452 1
Fax:+39 02 95452 300

Get Driving Directions:

Get Directions

>>> New Brochure <<< Click here to read CordenPharma Caponago's New Brochure
 

Core Capabilities

  • Experts in formulating and packaging parenteral dosage forms
  • Sterile emulsion technology
  • Pre-filled syringes
  • Distribution of clinical trial medication
  • Formulation development


CordenPharma Capanago Facility Capacities

Corporate Governance

Compliance Approvals

  • EMEA (AIFA)
  • FDA
  • ANVISA
  • TGA
  • Japanese MoH

SHE Certification

Facility Legacy

CordenPharma Caponago, is a cGMP manufacturer of sterile liquid dosage forms for injectable use with specialised expertise in sterile emulstion technology as well as a full range of capabilities including formulation development and manufacturing, generic manufacturing, clinical trials management, Carbapenem testing and packaging and pharma-logistics.

As s former AstraZeneca operations site, CordenPharma Caponago brings over 20 years of experience to CordenPharma’s full-service CMO platform with a particular focus in sterile emulsion technology, covering all steps from the emulsion preparation, filling, and terminal sterilisation to inspection, labeling and packaging. The site is inspected by EMEA (AIFA), FDA, ANVISA, TGA, and the Japanese Authority.
 

History

  • 1970 Foundation

  • 1987 Expansion to accommodate Diprivan

  • 1991 Further expansion 

  • 1992 First FDA approval

  • 2001 Acquired ex –Upjohn Plant

  • 2005 New plant for Carbapenemic packaging and analysis
  • 2007 Latest Anvisa (Brasilian)Audit

  • 2009 Acquired by ICIG to become CordenPharma Caponago S.p.A.

  • 2009 Latest FDA Audit

  • 2009 Latest Italian MoH Audit (AIFA)
  • 2011 Italian AIFA & FDA combined audit
  • 2012 Italian MoH Veterinary approval